About
Briya is transforming medical research by redefining how researchers access, interact with, and extract insights from healthcare data. It simplifies the traditionally fragmented and complex process of data analysis by converging, harmonizing, and standardizing diverse data sources, completely eliminating the need for complex coding and labor-intensive data cleaning.
With Briya’s flagship product, AIRE, Briya introduced the first clinical-grade AI research environment. Acting as an intelligent virtual research assistant and epidemiologist, AIRE enables researchers to seamlessly explore and analyze complex, multi-source medical data (both structured and unstructured) with unmatched speed and precision. Equipped with nine purpose-built AI agents, AIRE supports users through every stage: defining study designs and patient cohorts, testing hypotheses, visualizing trends, conducting advanced analyses, and accelerating the entire journey from data to discovery. All of this is achieved through an intuitive, natural-language enabled interface that integrates effortlessly into existing workflows and networks.
Maintaining the highest standards of privacy and compliance, and backed by leading investors such as Insight Partners, Team8, Amiti, and Innocare Health, Briya is leading a paradigm shift from static, siloed data toward dynamic, AI-driven research workflows, reshaping evidence generation and powering the future of healthcare innovation.
Funding history · 2 rounds · $17.0M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was Briya founded and what was its initial funding?
- Briya was founded in October 2020. In April 2022, Briya emerged from stealth with $5.5 million in Seed funding, led by Amiti Ventures.
- What significant funding round did Briya complete in 2023?
- In September 2023, Briya completed an $11.5 million Series A funding round, led by Team8.
- What is Briya's flagship product and its primary function?
- Briya's flagship product is AIRE, the first clinical-grade AI research environment. AIRE functions as an intelligent virtual research assistant and epidemiologist, enabling researchers to explore and analyze complex, multi-source medical data using natural language.
- What was a key strategic collaboration for Briya in September 2024?
- In September 2024, MSD, a multinational pharmaceutical company, successfully completed a strategic collaboration with Briya for innovative real-world evidence (RWE) data analysis projects.
- What significant appointment did Briya make in June 2024?
- In June 2024, renowned Public Health Expert Prof. Siegal Sadetzki joined Briya.
- What partnership did Briya announce in September 2025?
- In September 2025, Briya announced a strategic partnership with Tanner Health to develop new pathways for clinicians and researchers to access insights, aiming to accelerate clinical innovation and improve patient care in the Southern US.
- What initiative did Briya launch in September 2025 regarding its AIRE product?
- In September 2025, following the launch of Briya AIRE, the company announced it would offer free access to AIRE for select academic institutions to support critical medical research.
- What milestone did Briya achieve in April 2026 regarding its data network?
- In April 2026, Briya announced that its global data network had expanded to cover over 120 million patient journeys, aiming to accelerate AI-driven medical research.
- What appointment did Briya make in February 2026 to accelerate growth?
- In February 2026, Briya appointed Brian Creighton as Executive to accelerate growth in AI-driven healthcare data.